
Giving melanoma patients a “personalized” vaccine can prompt an anti-tumor immune response that lasts for years, an early study finds. The study involved just eight patients with advanced melanoma, the deadliest form of skin cancer. But it builds on earlier work showing it is possible to spur the immune system to respond to an individual’s… read on > read on >